These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10913499)

  • 1. Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease.
    Isaacsohn JL; Davidson MH; Hunninghake D; Singer R; McLain R; Black DM
    Am J Cardiol; 2000 Jul; 86(2):250-2. PubMed ID: 10913499
    [No Abstract]   [Full Text] [Related]  

  • 2. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Ricciardi MJ; Davidson CJ
    N Engl J Med; 1999 Dec; 341(24):1854; author reply 1854-5. PubMed ID: 10610465
    [No Abstract]   [Full Text] [Related]  

  • 3. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.
    Pitt B; Waters D; Brown WV; van Boven AJ; Schwartz L; Title LM; Eisenberg D; Shurzinske L; McCormick LS
    N Engl J Med; 1999 Jul; 341(2):70-6. PubMed ID: 10395630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ["Treating to New Targets": plea for a LDL cholesterol target of or below 75 mg/dl in any patient with coronary heart disease].
    Scheen AJ
    Rev Med Liege; 2005 Apr; 60(4):264-7. PubMed ID: 15943105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disturbances in cholesterol metabolism].
    Marschall HU
    Dtsch Med Wochenschr; 2001 Jan; 126(3):63-4. PubMed ID: 11205483
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized evaluation of atorvastatin in patients with coronary heart disease: a serial intravascular ultrasound study.
    Yamada T; Azuma A; Sasaki S; Sawada T; Matsubara H;
    Circ J; 2007 Dec; 71(12):1845-50. PubMed ID: 18037734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atorvastatin].
    Kajinami K; Takekoshi N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():598-604. PubMed ID: 11347138
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of simvastatin and atorvastatin in hypercholesterolemic patients.
    Bolaman Z; Kadikoylu G
    Clin Ther; 2003 Oct; 25(10):2631-3. PubMed ID: 14667963
    [No Abstract]   [Full Text] [Related]  

  • 9. Atorvastatin versus simvastatin.
    Calder RA
    Am J Cardiol; 1997 Dec; 80(12):1646. PubMed ID: 9416964
    [No Abstract]   [Full Text] [Related]  

  • 10. Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):7-8. PubMed ID: 16455005
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of atorvastatin of the treatment of hypercholesterolemia after renal transplantation.
    Alvarez ML; Errasti P; Gómez G; Lavilla FJ; García N; Ballester B; García I; Purroy A
    Transplant Proc; 1999 Sep; 31(6):2328-9. PubMed ID: 10500602
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dual cholesterol inhibition. More high risk patients achieve LDL cholesterol values below 100 mg/dl].
    MMW Fortschr Med; 2008 Jun; 150(23):39. PubMed ID: 18575369
    [No Abstract]   [Full Text] [Related]  

  • 13. [Decreasing LDL level moderately or drastically. Is differential therapy with statins available? (interview by Dirk Einecke)].
    März W
    MMW Fortschr Med; 2004 Jul; 146(27-28):53. PubMed ID: 15526673
    [No Abstract]   [Full Text] [Related]  

  • 14. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.
    Mikhailidis DP; Wierzbicki AS
    Curr Med Res Opin; 2002; 18(4):215-9. PubMed ID: 12201622
    [No Abstract]   [Full Text] [Related]  

  • 15. Rationale and design of the Myocardial Ischemia Reduction With Aggressive Cholesterol lowering (MIRACL) Study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.
    Ghali JK
    Am J Cardiol; 1998 Sep; 82(5):703. PubMed ID: 9732912
    [No Abstract]   [Full Text] [Related]  

  • 16. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use in a "real-world" clinical setting: aggressive lipid lowering compared with usual care in the Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE) trial.
    Koren MJ
    Am J Med; 2005 Dec; 118 Suppl 12A():16-21. PubMed ID: 16356803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.
    Bloom JM
    N Engl J Med; 1999 Dec; 341(24):1854-5. PubMed ID: 10610466
    [No Abstract]   [Full Text] [Related]  

  • 19. The benefits of intensive lipid lowering in patients with stable coronary heart disease with normal or high systolic blood pressure: an analysis of the Treating to New Targets (TNT) study.
    Kostis JB; Breazna A; Deedwania PC; LaRosa JC;
    J Clin Hypertens (Greenwich); 2008 May; 10(5):367-76. PubMed ID: 18453796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of the month. REVERAL and PROVE-IT: confirmation of the concept " the lower, the better" for cholesterol therapy in patients with coronary heart disease].
    Scheen AJ; Kulbertus H
    Rev Med Liege; 2004 Mar; 59(3):167-73. PubMed ID: 15139406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.